These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2865415)

  • 1. Testing and evaluation of opiate analgesics and antagonists.
    Hahn EF
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):373-81. PubMed ID: 2865415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans.
    Czakó B; Marton J; Berényi S; Gach K; Fichna J; Storr M; Tóth G; Sipos A; Janecka A
    Bioorg Med Chem; 2010 May; 18(10):3535-42. PubMed ID: 20413312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Opioids and the occurrence of pain].
    Herz A
    Internist (Berl); 1986 Jul; 27(7):412-7. PubMed ID: 2875044
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of blood serum proteins from the seal on the analgetic action of narcotic analgesics].
    Aslaniants ZhK; Melik-Eganov GR; Evstratov AV; Ivanov MP; Batrakov SG; Korobov NV; Iasnetsov VV
    Biull Eksp Biol Med; 1991 Nov; 112(11):503-5. PubMed ID: 1687360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
    Churiukanov VV
    Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and pharmacological activity of two new derivatives of benzazocine.
    Gutkowska B; Gumułka SW; Krzaścik P; Poppe I; Mészáros J; Makulska HE
    Pol J Pharmacol Pharm; 1991; 43(2):153-63. PubMed ID: 1658757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of opiate dependence.
    Villarreal JE; Herrera JE; Salazar LA
    Proc West Pharmacol Soc; 1985; 28():43-6. PubMed ID: 2999810
    [No Abstract]   [Full Text] [Related]  

  • 15. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholinergic, opioidergic and GABAergic neurotransmission of the dorsal hippocampus in the modulation of nociception in guinea pigs.
    Favaroni Mendes LA; Menescal-de-Oliveira L
    Life Sci; 2008 Nov; 83(19-20):644-50. PubMed ID: 18854195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the study of opioid receptors.
    Cox BM
    Mol Pharmacol; 2013 Apr; 83(4):723-8. PubMed ID: 23249538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
    Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
    J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.